ReviewTargeted oncology2012

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.

Andres Morales La Madrid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.